RESIDUAL CANCER BURDEN
Mark Identification

RESIDUAL CANCER BURDEN

Serial Number

97205532

Filing Date

Jan 6, 2022

Trademark by

DELPHI DIAGNOSTICS INC.

Classification Information

Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software

Medical Apparatus

Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer

Computer and Scientific

Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies

Medical, Beauty & Agricultural

Providing a website via a global computer network featuring a residual cancer burden calculator

Personal